163 related articles for article (PubMed ID: 23360883)
41. Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs.
Kverka M; Tlaskalova-Hogenova H
APMIS; 2013 May; 121(5):403-21. PubMed ID: 23094605
[TBL] [Abstract][Full Text] [Related]
42. [Inflammatory bowel disease: genetic or environmental diseases?].
Cortot A; Pineton de Chambrun G; Vernier-Massouille G; Vigneron B; Gower Rousseau C
Gastroenterol Clin Biol; 2009; 33(8-9):681-91. PubMed ID: 19716246
[TBL] [Abstract][Full Text] [Related]
43. Screening detects a high proportion of celiac disease in young HLA-genotyped children.
Björck S; Brundin C; Lörinc E; Lynch KF; Agardh D
J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):49-53. PubMed ID: 19915493
[TBL] [Abstract][Full Text] [Related]
44. Microbiota regulation of inflammatory bowel disease and colorectal cancer.
Liu Z; Cao AT; Cong Y
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482
[TBL] [Abstract][Full Text] [Related]
45. Dysbiosis a risk factor for celiac disease.
Girbovan A; Sur G; Samasca G; Lupan I
Med Microbiol Immunol; 2017 Apr; 206(2):83-91. PubMed ID: 28204873
[TBL] [Abstract][Full Text] [Related]
46. Genetic background of celiac disease and its clinical implications.
Wolters VM; Wijmenga C
Am J Gastroenterol; 2008 Jan; 103(1):190-5. PubMed ID: 18184122
[TBL] [Abstract][Full Text] [Related]
47. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases.
Lee KA; Lee WJ
Dev Comp Immunol; 2014 Jan; 42(1):102-10. PubMed ID: 23685204
[TBL] [Abstract][Full Text] [Related]
48. Etiology and pathogenesis of inflammatory bowel disease.
Schmidt C; Stallmach A
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
[TBL] [Abstract][Full Text] [Related]
49. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I
Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
[TBL] [Abstract][Full Text] [Related]
50. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
[TBL] [Abstract][Full Text] [Related]
51. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.
Vermeulen BA; Hogen Esch CE; Yuksel Z; Koning F; Verduijn W; Doxiadis II; Schreuder GM; Mearin ML
Scand J Gastroenterol; 2009; 44(1):40-5. PubMed ID: 18932050
[TBL] [Abstract][Full Text] [Related]
52. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A
Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
[TBL] [Abstract][Full Text] [Related]
53. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
54. Multi-omics analysis of inflammatory bowel disease.
Huang H; Vangay P; McKinlay CE; Knights D
Immunol Lett; 2014 Dec; 162(2 Pt A):62-8. PubMed ID: 25131220
[TBL] [Abstract][Full Text] [Related]
55. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease.
Chu H; Khosravi A; Kusumawardhani IP; Kwon AH; Vasconcelos AC; Cunha LD; Mayer AE; Shen Y; Wu WL; Kambal A; Targan SR; Xavier RJ; Ernst PB; Green DR; McGovern DP; Virgin HW; Mazmanian SK
Science; 2016 May; 352(6289):1116-20. PubMed ID: 27230380
[TBL] [Abstract][Full Text] [Related]
56. Microbiota and innate immunity in intestinal inflammation and neoplasia.
Cario E
Curr Opin Gastroenterol; 2013 Jan; 29(1):85-91. PubMed ID: 23207600
[TBL] [Abstract][Full Text] [Related]
57. Immunogenetic control of the intestinal microbiota.
Marietta E; Rishi A; Taneja V
Immunology; 2015 Jul; 145(3):313-22. PubMed ID: 25913295
[TBL] [Abstract][Full Text] [Related]
58. The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.
Pagliari D; Urgesi R; Frosali S; Riccioni ME; Newton EE; Landolfi R; Pandolfi F; Cianci R
J Immunol Res; 2015; 2015():123653. PubMed ID: 26090475
[TBL] [Abstract][Full Text] [Related]
59. The mucosal firewalls against commensal intestinal microbes.
Macpherson AJ; Slack E; Geuking MB; McCoy KD
Semin Immunopathol; 2009 Jul; 31(2):145-9. PubMed ID: 19707762
[TBL] [Abstract][Full Text] [Related]
60. A Touch of Youth in Gut Microbiota Development.
Magri G; Cerutti A
Immunity; 2016 Jul; 45(1):12-4. PubMed ID: 27438763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
